Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             554 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A biological basis for treating eating disorders Kaye, W.
 1996
 39 7 p. 665-
1 p.
 artikel
2 Abnormal categorical perception of simple speech sounds in schizophrenia Cienfiuegos, A.
 1996
 39 7 p. 576-
1 p.
 artikel
3 Abnormal D3 pre-mRNA processing in chronic schizophrenia Schmauss, C.
 1996
 39 7 p. 506-507
2 p.
 artikel
4 Abnormal peripheral benzodiazepine receptors in social phobia Johnson, M.R.
 1996
 39 7 p. 592-
1 p.
 artikel
5 A bridging study of lesopitron in generalized anxiety disorder Sramek, J.J.
 1996
 39 7 p. 622-
1 p.
 artikel
6 A controlled trial of fluvoxamine for OCD in children and adolescents Riddle, M.A.
 1996
 39 7 p. 568-
1 p.
 artikel
7 ACTH & β-endorphin over the menstrual cycle in women with PMS & controls Bloch, M.
 1996
 39 7 p. 648-649
2 p.
 artikel
8 Acupuncture: Physiological mechanisms and clinical application Ulett, G.A.
 1996
 39 7 p. 665-
1 p.
 artikel
9 Acute fluoxetine enhances cocaine's action on brain reward Chen, J.
 1996
 39 7 p. 537-
1 p.
 artikel
10 Adaptation of nmda receptors following antidepressant treatments Skolnick, P.
 1996
 39 7 p. 558-
1 p.
 artikel
11 Adenosylation of the dopamine D4 receptor causes spontaneous activity Kramer, M.L.
 1996
 39 7 p. 631-
1 p.
 artikel
12 Age and sex differences in human brain mu opioid receptor binding measured by PET Zubieta, J.K.
 1996
 39 7 p. 605-606
2 p.
 artikel
13 Age of illness onset and the inpatient drug washout Sharma, R.P.
 1996
 39 7 p. 553-
1 p.
 artikel
14 Age-related changes in formal thought disorder in chronic schizophrenic patients Lombardi, J.
 1996
 39 7 p. 549-
1 p.
 artikel
15 Agonist-induced internalization of the 5HT2A receptor in vitro Berry, S.A.
 1996
 39 7 p. 531-532
2 p.
 artikel
16 Alcoholism and age interact in their effects on brain function Ford, J.M.
 1996
 39 7 p. 617-
1 p.
 artikel
17 A longitudinal study of HPA axis dysfunction in Alzheimer's disease Lawlor, B.A.
 1996
 39 7 p. 644-
1 p.
 artikel
18 Altered response to intravenous d-fenfluramine during depression using [15O]-PET Meyer, J.
 1996
 39 7 p. 516-
1 p.
 artikel
19 Altered signal transduction in fibroblasts from first-episode schizophrenic patients Mahadik, S.P.
 1996
 39 7 p. 519-
1 p.
 artikel
20 Alternative strategies for quantifying speed of response in major depression Nobler, M.S.
 1996
 39 7 p. 649-
1 p.
 artikel
21 Alzheimer's-type pathology in schizophrenia with dementia Dwork, A.J.
 1996
 39 7 p. 510-511
2 p.
 artikel
22 Amesergide PRE-treatment of m-CPP in normal controls Wong, C.M.
 1996
 39 7 p. 585-
1 p.
 artikel
23 AMPA subunit gene expression in the frontal cortices of schizophrenics Healy, D.J.
 1996
 39 7 p. 539-
1 p.
 artikel
24 Amphetamine psychosis in male and female rhesus monkeys Castner, S.A.
 1996
 39 7 p. 590-591
2 p.
 artikel
25 A multiple fixed-dose, placebo-controlled trial with ‘Seroquel’: An atypical antipsychotic Borison, R.L.
 1996
 39 7 p. 597-598
2 p.
 artikel
26 Analysis of HLA-DRB1 alleles in alcoholism in Japanese Fujimoto, T.
 1996
 39 7 p. 541-
1 p.
 artikel
27 An analysis of olfactory deficits in schizophrenia Serby, M.
 1996
 39 7 p. 551-
1 p.
 artikel
28 A neural network model of Stroop interference and facilitation effects in schizophrenia Cohen, J.D.
 1996
 39 7 p. 568-
1 p.
 artikel
29 A nonhuman primate model of type II excessive alcohol consumption Higley, J.D.
 1996
 39 7 p. 561-
1 p.
 artikel
30 An open-label study of fluvoxamine in body dysmorphic disorder Phillips, K.A.
 1996
 39 7 p. 625-
1 p.
 artikel
31 An open label trial of venlafaxine in adults with attention deficit disorder Adler, L.A.
 1996
 39 7 p. 622-
1 p.
 artikel
32 Anorexia nervosa: Prevention of relapse Halmi, K.A.
 1996
 39 7 p. 666-
1 p.
 artikel
33 Antibodies to human heat shock protein in patients with schizophrenia and major depression Sirota, P.
 1996
 39 7 p. 583-
1 p.
 artikel
34 Anticholinergic eye drops in differentiating Alzheimer's disease and depression Schweitzer, I.
 1996
 39 7 p. 662-
1 p.
 artikel
35 Anticonvulsants and lithium in “mixed” vs, “pure” mania Goldberg, J.F.
 1996
 39 7 p. 621-622
2 p.
 artikel
36 Antidepressant maintenance medications: A critical review Greden, J.F.
 1996
 39 7 p. 611-
1 p.
 artikel
37 Antidepressant response to oral pulse loading with clomipramine Dube, S.
 1996
 39 7 p. 623-
1 p.
 artikel
38 Anti-inflammatory drug studies in Alzheimer's disease Aisen, P.S.
 1996
 39 7 p. 563-
1 p.
 artikel
39 Antipsychotic drug dosing Davis, J.M.
 1996
 39 7 p. 596-597
2 p.
 artikel
40 Antisense “knockdown” of CRH1- but not of CRH2-Receptors is anxiolytic in rats Montkowski, A.
 1996
 39 7 p. 566-567
2 p.
 artikel
41 A one year randomized trial of clozapine vs. usual care in bipolar I patients Suppes, T.
 1996
 39 7 p. 531-
1 p.
 artikel
42 AP-2 activation of phenylethanolamine N-methyltransferase gene expression Wong II, D.L.
 1996
 39 7 p. 538-
1 p.
 artikel
43 A parametric study of the rat N40 evoked response Boutros, N.
 1996
 39 7 p. 652-
1 p.
 artikel
44 A pet study of bulimia nervosa reveals caudate hypermetabolism Klein, E.A.
 1996
 39 7 p. 603-
1 p.
 artikel
45 A PET study of FDG metabolism in abstaining cocaine addicts Wu, J.C.
 1996
 39 7 p. 607-
1 p.
 artikel
46 A PET study of PET FDOPA uptake in abstaining cocaine addicts Bell, K.M.
 1996
 39 7 p. 606-
1 p.
 artikel
47 Apolipoprotein is a susceptibility genetic locus that affects the expression of late-onset familial and sporadic Alzheimer's disease Roses, A.D.
 1996
 39 7 p. 562-
1 p.
 artikel
48 A polymorphism in tryptophan hydroxylase and irritable aggression in personality disorders New, A.S.
 1996
 39 7 p. 506-
1 p.
 artikel
49 Apoptosis in the rat dentate gyrus: The effect of aging, stimulation by dexamethasone, and the apparent protective role of corticosterone Hassan, A.H.S.
 1996
 39 7 p. 582-
1 p.
 artikel
50 A potential novel binding site for mao inhibitors in brain Levant, B.
 1996
 39 7 p. 593-
1 p.
 artikel
51 A protocol for an animal model for neuroimmunologic psychiatric disease Black, J.L.
 1996
 39 7 p. 645-
1 p.
 artikel
52 A quantitative volumetric MRI study of the brainstem and cerebellum in schizophrenia Levitt, J.J.
 1996
 39 7 p. 639-
1 p.
 artikel
53 Are response inhibition failures in OCD related to abnormal fronto-striatal circuits? O’Hearn, K.
 1996
 39 7 p. 524-525
2 p.
 artikel
54 A role for CREB and BDNF in the actions of antidepressants Duman, R.S.
 1996
 39 7 p. 558-559
2 p.
 artikel
55 A schizophrenia profile of regional cortical gray matter deficits Sullivan, E.V.
 1996
 39 7 p. 600-
1 p.
 artikel
56 A search for schizophrenia genes by affected sib-pair analysis WiIdenauer, D.B.
 1996
 39 7 p. 614-
1 p.
 artikel
57 Assessment of striatal dopamine function in schizophrenia Breier, A.
 1996
 39 7 p. 513-
1 p.
 artikel
58 Associated psychiatric syndromes in chronic schizophrenia Bermanzohn, P.C.
 1996
 39 7 p. 543-
1 p.
 artikel
59 Association of schizophrenia with VCFS and 22q11 deletions Morrow, B.E.
 1996
 39 7 p. 540-
1 p.
 artikel
60 Astrocytes and brain energy metabolism: Possible influence on eating behavior Magistretti, P.J.
 1996
 39 7 p. 504-
1 p.
 artikel
61 Asymmetric current density as depressives evaluate life events Luu, P.
 1996
 39 7 p. 566-
1 p.
 artikel
62 A trait marker for panic disorder Coryell, W.H.
 1996
 39 7 p. 567-
1 p.
 artikel
63 Atropine reduces neuronal activity in cortical, but not subcortical regions of rat brain Hammer Jr., R.P.
 1996
 39 7 p. 589-
1 p.
 artikel
64 Atropine selectively reduces metabolic activity in rat cerebral cortex Jacobson, S.A.
 1996
 39 7 p. 590-
1 p.
 artikel
65 Attentional and eye movement dysfunctions in schizophrenia Obuchowski, M.
 1996
 39 7 p. 572-
1 p.
 artikel
66 Attention and sensory gating deficits in relatives of schizophrenic patients Freedman, R.
 1996
 39 7 p. 501-
1 p.
 artikel
67 Atypical antipsychotic medication in the treatment of first episode schizophrenia Sheltrnan, B.
 1996
 39 7 p. 520-
1 p.
 artikel
68 Auditory and visual high density ERP studies in schizophrenia Potts, G.F.
 1996
 39 7 p. 566-
1 p.
 artikel
69 Auditory evoked potentials in schizophrenia Boutros, N.
 1996
 39 7 p. 651-
1 p.
 artikel
70 Auditory hallucinations: Relationship to diagnosis & severity of illness characteristics Elliott, A.J.
 1996
 39 7 p. 544-545
2 p.
 artikel
71 Author index 1996
 39 7 p. 667-677
11 p.
 artikel
72 Autism and the x-chromosome: Multipoint SIB pair analysis Halmayer, J.
 1996
 39 7 p. 541-542
2 p.
 artikel
73 Autocovariance based analysis of functional MRI data Maas, L.C.
 1996
 39 7 p. 640-641
2 p.
 artikel
74 Automated measurement of subcortical brain MR structures in schizophrenia Iosifescu, D.V.
 1996
 39 7 p. 640-
1 p.
 artikel
75 Awards 1996
 39 7 p. x-xi
nvt p.
 artikel
76 Basal ganglia morphology in geriatric Mania Bocksberger, J.P.
 1996
 39 7 p. 661-
1 p.
 artikel
77 Baseline and follow-up mesiotemporal volumes in first episode schizophrenics Strous, R.D.
 1996
 39 7 p. 519-520
2 p.
 artikel
78 Behavioral effects of Venlafaxine in children and adolescents Mandoki, M.
 1996
 39 7 p. 621-
1 p.
 artikel
79 Behavioral inhibition study of offspring of depressed and anxious adults Fairbanks, J.M.
 1996
 39 7 p. 523-
1 p.
 artikel
80 Behavioral studies in neurodevelopment Walker, E.F.
 1996
 39 7 p. 556-
1 p.
 artikel
81 Benzodiazepine sensitivity in panic and obsessive-compulsive disorders Roy-Byrne, P.
 1996
 39 7 p. 620-
1 p.
 artikel
82 Beyond efficacy: Treatment outcome in panic disorder Mavissakalian, M.
 1996
 39 7 p. 568-
1 p.
 artikel
83 Biological aspects of misperceptions Ciprian-Ollivier, J.
 1996
 39 7 p. 563-
1 p.
 artikel
84 Biological \ldmarkers\rd in dysthymia Dunn, E.J.
 1996
 39 7 p. 526-
1 p.
 artikel
85 Biological psychiatry: Fifty years of progress Halmi, Katherine A.
 1996
 39 7 p. xii-
1 p.
 artikel
86 Biosynthesis of the dopamine D1, D4, and D5 receptor polypeptides Bergson, C.
 1996
 39 7 p. 632-
1 p.
 artikel
87 Blunted neuroendocrine response to citalopram challenge in diabetes (type 1) Schindler, S.D.
 1996
 39 7 p. 647-
1 p.
 artikel
88 Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder FitzGerald, M.
 1996
 39 7 p. 645-646
2 p.
 artikel
89 Brain beg abnormalities in 300 hospitalized preadolescents Gehm, N.K.
 1996
 39 7 p. 657-658
2 p.
 artikel
90 Brain CSF volume in patients with first-episode psychosis Hirayasu, Y.
 1996
 39 7 p. 519-
1 p.
 artikel
91 Brain glucose metabolic rates in alcoholic patients Williams, W.
 1996
 39 7 p. 536-
1 p.
 artikel
92 Brain GMR in schizophrenics and controls matched for CPT score Siegel Jr., B.V.
 1996
 39 7 p. 601-602
2 p.
 artikel
93 Brain imaging correlates of cue-induced cocaine craving O’Brien, C.P.
 1996
 39 7 p. 509-
1 p.
 artikel
94 Brain imaging in late-life onset schizophrenia Pearlson, G.D.
 1996
 39 7 p. 510-
1 p.
 artikel
95 Brain imaging to determine the effects of sertindole in schizophrenic patients Potkin, S.
 1996
 39 7 p. 514-
1 p.
 artikel
96 Brain metabolism and sleep deprivation: A PET study Wu, J.C.
 1996
 39 7 p. 605-
1 p.
 artikel
97 Brain noradrenergic receptors in major depression and schizophrenia Ordway, G.A.
 1996
 39 7 p. 587-
1 p.
 artikel
98 Brain stimulation reverses cerebral metabolic reductions in Alzheimer disease Pietrini, P.
 1996
 39 7 p. 660-
1 p.
 artikel
99 Brofaromine in social phobia—Recent findings from a US trial Katz, R.J.
 1996
 39 7 p. 618-
1 p.
 artikel
100 B37 trinucleotide repeats in schizophrenic patients and french and african controls Morris-Rosendahl, D.J.
 1996
 39 7 p. 541-
1 p.
 artikel
101 Bulimia nervosa: Which treatment is best? Mitchell, J.E.
 1996
 39 7 p. 665-666
2 p.
 artikel
102 Caudate nucleus and putamen abnormalities in pediatric OCD Rosenberg, D.
 1996
 39 7 p. 606-
1 p.
 artikel
103 CBF activation in post traumatic stress disorder: Spect studies Liberzon, I.
 1996
 39 7 p. 553-554
2 p.
 artikel
104 Cellular substrates for serotonergic modulation of gaba in the nucleus accumbens Van Bockstaele, E.J.
 1996
 39 7 p. 532-
1 p.
 artikel
105 Cerebellar volume deficits in schizophrenia Deshmukh, A.
 1996
 39 7 p. 600-
1 p.
 artikel
106 Cerebrospinal fluid 5-HIAA is low in perpetrators of domestic violence George, D.T.
 1996
 39 7 p. 535-536
2 p.
 artikel
107 Childhood onset schizophrenia: New research Rapoport, J.L.
 1996
 39 7 p. 507-
1 p.
 artikel
108 Cholinergic hypersensitivity in intestinal allergy and depression Djuric, V.J.
 1996
 39 7 p. 527-
1 p.
 artikel
109 Cholinesterase inhibitor alters escape/reversal in ach-sensitive rats Lyon, M.
 1996
 39 7 p. 591-592
2 p.
 artikel
110 Chronic corticosterone on mesocortical dopamine utilization Lindley, S.E.
 1996
 39 7 p. 629-
1 p.
 artikel
111 Chronicity and neuropsychological dysfunction in schizophrenia Smet, I.C.
 1996
 39 7 p. 579-
1 p.
 artikel
112 CI-988, a cholecystoklnin-B antagonist, in panic disorder Pande, A.C.
 1996
 39 7 p. 619-620
2 p.
 artikel
113 Cigarette smoking and psychiatric illness: A va outpatient survey Dalack, G.W.
 1996
 39 7 p. 547-
1 p.
 artikel
114 Cingulate cortex presynaptic proteins in schizophrenia Honer, W.G.
 1996
 39 7 p. 518-
1 p.
 artikel
115 Circadian rest-activity rhythms in demented nondemented elders and their caregivers Pollak, C.P.
 1996
 39 7 p. 661-
1 p.
 artikel
116 Clinical and neuropsychological deficits in bipolar and schizophrenic patients Smith, A.
 1996
 39 7 p. 580-581
2 p.
 artikel
117 Clinical correlates of perceptual organization dysfunction in schizophrenia Silverstein, S.M.
 1996
 39 7 p. 577-
1 p.
 artikel
118 Clinical evaluation for studies of gonadal hormones and mood Endicott, J.
 1996
 39 7 p. 613-
1 p.
 artikel
119 Clinical, neuroendocrine and treatment studies of impulsive aggression Coccaro, E.F.
 1996
 39 7 p. 561-
1 p.
 artikel
120 Clinical studies supporting genetic research in anorexia nervosa Kaye, W.
 1996
 39 7 p. 504-
1 p.
 artikel
121 Clonidine treatment of aggression in an autistic adult Villalba II, R.
 1996
 39 7 p. 538-
1 p.
 artikel
122 Clozapine treatment of childhood-onset schizophrenia Kumra, S.
 1996
 39 7 p. 530-
1 p.
 artikel
123 Clozapine treatment of children and adolescents: A four year follow-up Kowatch, R.A.
 1996
 39 7 p. 530-
1 p.
 artikel
124 Cluster analysis of MRI regional brain volumes in schizophrenia Mathalon, D.H.
 1996
 39 7 p. 640-
1 p.
 artikel
125 11C NMSP receptor occupancy by clozapine and haloperidol in schizophrenic subjects Conley, R.
 1996
 39 7 p. 514-
1 p.
 artikel
126 Cocaine effects on dopamine transporter mRNA in human users Little, K.Y.
 1996
 39 7 p. 634-
1 p.
 artikel
127 Cocaine reduces cerebral blood volume in humans: Detection with DSC MRI Kaufman, M.J.
 1996
 39 7 p. 641-
1 p.
 artikel
128 Cocaine-related cues elicit craving and activate cortical circuits relevant to episodic memory London, E.D.
 1996
 39 7 p. 509-
1 p.
 artikel
129 Cognitive and PET studies of postmenopausal women Chakravorty, S.G.
 1996
 39 7 p. 644-
1 p.
 artikel
130 Cognitive impairment in elderly depressed individuals with APOE ∈4 Tupler, L.A.
 1996
 39 7 p. 659-
1 p.
 artikel
131 Cognitive impairment in elderly schizophrenics: Phenomenology, longitudinal course, and neuropathology Mohs, R.C.
 1996
 39 7 p. 612-
1 p.
 artikel
132 Cognitive impairment in euthymic patients with bipolar affective disorder van Gorp, W.G.
 1996
 39 7 p. 580-
1 p.
 artikel
133 Cognitive improvement in Alzheimer's disease: Use of the CNTB in a trial of xanomeline Cutler, N.R.
 1996
 39 7 p. 660-661
2 p.
 artikel
134 Cognitive impulsivity in adolescent conduct disorder and depression Pogge, D.L.
 1996
 39 7 p. 536-
1 p.
 artikel
135 Cognitive psychophysiology in anxiolytic drug research Semlitsch, H.V.
 1996
 39 7 p. 656-
1 p.
 artikel
136 Co-Morbidity of attention deficit disorder in adult patients screened for PTSD Adler, L.A.
 1996
 39 7 p. 554-
1 p.
 artikel
137 Comorbidity of premenstrual depression and postpartum blues among Chinese women Ko, H-C.
 1996
 39 7 p. 648-
1 p.
 artikel
138 Comparative effects of nefazodone & fluoxetine on sleep in outpatients with major depressive disorder Armitage, R.
 1996
 39 7 p. 623-
1 p.
 artikel
139 Comparison of clomipramine vs. fenfluramine challenges Nicholas, L.M.
 1996
 39 7 p. 620-
1 p.
 artikel
140 Computer modeling of adaptive depression and asymmetric hemispheric processing Webster, C.
 1996
 39 7 p. 580-
1 p.
 artikel
141 Conduct disorder, impulsivity, and substance abuse in adolescents Pogge, D.L.
 1996
 39 7 p. 536-537
2 p.
 artikel
142 Context processing disturbances in schizophrenia: Empirical test of a theoretical model Cohen, J.D.
 1996
 39 7 p. 608-609
2 p.
 artikel
143 Controlled study of antidepressant treatment of postpartum depression Epperson, C.N.
 1996
 39 7 p. 618-
1 p.
 artikel
144 Control of renal factors in plasma HVA measurements Amin, F.
 1996
 39 7 p. 633-634
2 p.
 artikel
145 Cortical circuits involved in cocaine sensitization during withdrawal Hammer Jr., R.P.
 1996
 39 7 p. 509-
1 p.
 artikel
146 Cortical function in schizophrenia during blood flow activation Taylor, S.F.
 1996
 39 7 p. 606-
1 p.
 artikel
147 Cortical responses to threat-related words in normal subjects and patients with panic disorder: An fMRI study Maddock, R.J.
 1996
 39 7 p. 637-
1 p.
 artikel
148 Cortisol and maternal attraction to infant odor Steiner, M.
 1996
 39 7 p. 527-
1 p.
 artikel
149 Course of psychotic disorders in women: Influence of menstrual cycle phase Schechter, D.
 1996
 39 7 p. 646-
1 p.
 artikel
150 CSF epinephrine in aging and Alzheimer's disease Peskind, E.R.
 1996
 39 7 p. 659-660
2 p.
 artikel
151 CSF monoamine metabolites in alcoholics with and without nicotine addiction Ragan, P.W.
 1996
 39 7 p. 627-
1 p.
 artikel
152 CSF neuropeptide dysregulation in patients with affective disorder Frye, M.A.
 1996
 39 7 p. 596-
1 p.
 artikel
153 Current models of schizophrenia: Explanatory potential LoboPrabhu, S.
 1996
 39 7 p. 545-
1 p.
 artikel
154 Cytochrome P450-26 (CYP2D6) genotype: Relationship with clozapine and haloperidol metabolism de Leon, J.
 1996
 39 7 p. 591-
1 p.
 artikel
155 Cytokine regulation of apoptosis in fetal substantia nigra cultures Jarskog, L.F.
 1996
 39 7 p. 582-
1 p.
 artikel
156 Dana consortium on the genetic basis of manic depressive illness: Chromosome 18 update DePaulo, J.R.
 1996
 39 7 p. 615-
1 p.
 artikel
157 Dawn simulation treatment of abstinent alcoholics with winter depression Avery, D.H.
 1996
 39 7 p. 620-621
2 p.
 artikel
158 Daytime sleepiness in young adults Breslau, N.
 1996
 39 7 p. 620-
1 p.
 artikel
159 D4DR exon III polymorphism association with personality variation in normals Ebstein, R.P
 1996
 39 7 p. 564-
1 p.
 artikel
160 Decoupled rotational and translational image registration for functional MRI data sets Maas, L.C.
 1996
 39 7 p. 641-
1 p.
 artikel
161 Decreased caudate volume in first episode schizophrenia Keshavan, M.S.
 1996
 39 7 p. 556-557
2 p.
 artikel
162 Decreased [3H]cAMP binding in postmortem brain in bipolar disorder Feifel, D.
 1996
 39 7 p. 583-584
2 p.
 artikel
163 Decreased level of N-acetylaspartate in basal ganglia of patients with alcoholism Uchida, T.
 1996
 39 7 p. 595-
1 p.
 artikel
164 Defective utilization of precursor essential fatty acids in schizophrenia Mahadik, S.P.
 1996
 39 7 p. 588-
1 p.
 artikel
165 Delayed visual processing ERP negativity (NA) in chronic schizophrenia Saito, H.
 1996
 39 7 p. 653-
1 p.
 artikel
166 Depressive personality characteristics and clinical depression Hartlage, S.
 1996
 39 7 p. 524-
1 p.
 artikel
167 Determinants of category and phonemic fluency dificits in chronic schizophrenics Harvey, P.D.
 1996
 39 7 p. 575-576
2 p.
 artikel
168 Determination of salivary cortisol by non-radioisotopic immunoassay Yao, J.K.
 1996
 39 7 p. 642-
1 p.
 artikel
169 Developmental abnormalities of the prefrontal cortex in schizophrenia Akbarian, S.
 1996
 39 7 p. 557-
1 p.
 artikel
170 Developmental continuities in anxiety and anxiety disorders Klein, R.G.
 1996
 39 7 p. 508-
1 p.
 artikel
171 Developmental morphology of the corpus callosum in healthy and first-break schizophrenic subjects Bagwell, W.W.
 1996
 39 7 p. 518-
1 p.
 artikel
172 Development of auditory continuous performance tasks for functional MRI Seidman, L.J.
 1996
 39 7 p. 636-
1 p.
 artikel
173 Development of limbic cortex and circuits Levitt, P.
 1996
 39 7 p. 557-
1 p.
 artikel
174 3-D fMRI of working memory in schizophrenia Callicott, J.H.
 1996
 39 7 p. 636-
1 p.
 artikel
175 DHEA-S and decline in HIV-1 associated cognitive/motor functioning Silva, S.G.
 1996
 39 7 p. 663-
1 p.
 artikel
176 Differential activation of ZIF268 in the amygdala in response to mCPP Altemus, M.
 1996
 39 7 p. 583-
1 p.
 artikel
177 Differential effects of alprazolam and lorazepam on plasma cortisol in normal elderly Pomara, N.
 1996
 39 7 p. 624-625
2 p.
 artikel
178 Differential effects of typical and atypical antipsychotic medication on plasma prolactin levels Lee, H.
 1996
 39 7 p. 529-
1 p.
 artikel
179 Differential effects of typical and atypical antipsychotics on 5-HT release Kuroki, T.
 1996
 39 7 p. 533-534
2 p.
 artikel
180 Differential localization of D2, D3, and D4 mRNA in midgestational human forebrain by in situ hybridization Unis, A.S.
 1996
 39 7 p. 632-
1 p.
 artikel
181 Differential patterns of dopamine receptor gene expression in schizophrenia Meador-Woodruff, J.H.
 1996
 39 7 p. 505-
1 p.
 artikel
182 Differential regulation of non-NMDA subunit mRNA by antipsychotics in rat Healey, D.J.
 1996
 39 7 p. 587-
1 p.
 artikel
183 Differentiating dopamine D2 ligands by their sensitivities to modification of Cys118 Javitch, J.A.
 1996
 39 7 p. 630-631
2 p.
 artikel
184 Differing relationship of cholinergic and catecholaminergic neurotransmission to sensory gating in schizophrenic patients, bipolar patients, and normal subjects Adler, L.E.
 1996
 39 7 p. 651-
1 p.
 artikel
185 Diminished pulse-respiration-coupling in depressed patients Lehofer, M.
 1996
 39 7 p. 526-
1 p.
 artikel
186 Disordered brain functional connectivity during hallucinations in a schizophrenic patient Silbereweig, D.
 1996
 39 7 p. 516-
1 p.
 artikel
187 Disordered time perception following unilateral amobarbital injection Drane, D.L.
 1996
 39 7 p. 575-
1 p.
 artikel
188 Dissociating selective attention and strees in the Stroop interference paradigm Taylor, S.F.
 1996
 39 7 p. 569-
1 p.
 artikel
189 Dissociation of P1/P50 subcomponent abnormalities in schizophrenia Erwin, R.J.
 1996
 39 7 p. 652-
1 p.
 artikel
190 Distinct memory deficits from bilateral vs. unilateral electroconvulsive seizures Francis, A.
 1996
 39 7 p. 651-
1 p.
 artikel
191 Disturbances of auditory localization and trajectory discrimination in schizophrenia Breene, R.W.
 1996
 39 7 p. 580-
1 p.
 artikel
192 Disturbed thought and information processing deficits in schizophrenia Perry, W.
 1996
 39 7 p. 549-
1 p.
 artikel
193 Does serotonin blockade alter antipsychotic drug response? Davis, J.M.
 1996
 39 7 p. 597-
1 p.
 artikel
194 Domains of psychopathology: Is schizophrenia different from other psychoses? Ratkonda, S.S.
 1996
 39 7 p. 542-
1 p.
 artikel
195 Dopaminergic modulation of frontal activity: Involvement in cocaine addiction Volkow, N.D.
 1996
 39 7 p. 508-509
2 p.
 artikel
196 Dopamine transporter in schizophrenia: A progressive loss with age in the cingulate cortex Hitri, A.
 1996
 39 7 p. 505-506
2 p.
 artikel
197 Dose-related effects of clozapine on tardive dyskinesia among “treatment-refractory” patients with schizophrenia Nair, C.
 1996
 39 7 p. 529-530
2 p.
 artikel
198 Do the antidepressants have anxiogenic action? Allikmets, L.
 1996
 39 7 p. 626-
1 p.
 artikel
199 Double-blind comparison of amitriptyline and fluoxetine efficacy and tolerance Ontiveros, A.
 1996
 39 7 p. 619-
1 p.
 artikel
200 Double-blind comparison of sexual dysfunction on imipramine and paroxetine Ontiveros, A.
 1996
 39 7 p. 618-619
2 p.
 artikel
201 Double-blind study of double depression response to antidepressants Perez, M.
 1996
 39 7 p. 619-
1 p.
 artikel
202 D2 — Receptor imaging (SPECT) as a tool for measuring the efficacy and side-effect profile of treatment with neuroleptics Kasper, S.
 1996
 39 7 p. 564-
1 p.
 artikel
203 D2 Receptor occupancy in risperidone and clozapine-treated schizophrenics Su, T.-P.
 1996
 39 7 p. 513-514
2 p.
 artikel
204 Dynamic contrast MRI of cerebral blood volume compared with spect in Alzhemer's disease Harris, F.J.
 1996
 39 7 p. 641-
1 p.
 artikel
205 Early intervention in schizophrenia improves the long-term course of the illness Wyatt, R.J.
 1996
 39 7 p. 612-
1 p.
 artikel
206 EEG resonant responses to photic stimulation following SDZ MAR-327 treatment Jin, Y.
 1996
 39 7 p. 657-
1 p.
 artikel
207 Effect of chronic ethanol treatment on hippocampal CA3 neurons Ownby, R.L.
 1996
 39 7 p. 506-
1 p.
 artikel
208 Effect of chronic stress and antidepressants in rat hippocampal function Zimmer, C.A.
 1996
 39 7 p. 589-
1 p.
 artikel
209 Effect of ECT on plasma homovanillic acid in elderly major depression: Preliminary findings Lee, H.
 1996
 39 7 p. 649-650
2 p.
 artikel
210 Effect of nicotine and stage 2 sleep on auditory P50 gating in schizophrenia Griffith, J.M.
 1996
 39 7 p. 652-
1 p.
 artikel
211 Effect of paroxetine on heart rate variability in panic disorder: Analysis of holter records Yeragani, V.
 1996
 39 7 p. 522-
1 p.
 artikel
212 Effects of amphetamine on cognitive impairment in schizotypal personality disorder Kirrane, R.
 1996
 39 7 p. 581-
1 p.
 artikel
213 Effects of d- and d,l-fenfluramine on emotions in males Berman, M.
 1996
 39 7 p. 537-
1 p.
 artikel
214 Effects of intra-accumbens neurotensin on sensorimotor gating Feifel, D.
 1996
 39 7 p. 583-
1 p.
 artikel
215 Effects of typical and atypical antipsychotics on AMPA site binding McCoy, L.
 1996
 39 7 p. 586-
1 p.
 artikel
216 Efficacy and safety of three doses of sertindole and haloperidol in schizophrenic patients Bark, N.
 1996
 39 7 p. 597-
1 p.
 artikel
217 Electroconvulsive therapy and the neuroanatomy of mood disorders Sackeim, H.
 1996
 39 7 p. 511-512
2 p.
 artikel
218 Elevated cholecystokinin mRNA in dorsolateral prefrontal cortex in suicides Bachus, S.E.
 1996
 39 7 p. 630-
1 p.
 artikel
219 Elevated intracellular calcium in transformed lymphoblasts in bipolar I disorder Emamghoreishi, M.
 1996
 39 7 p. 584-
1 p.
 artikel
220 Elevated plasma lipid peroxides in schizophrenic patients without dementia Evans, D.R.
 1996
 39 7 p. 588-
1 p.
 artikel
221 Enhanced transmembrane signaling of 5-HT receptor in platelets of bipolar affective disorder subjects Friedman, E.
 1996
 39 7 p. 503-
1 p.
 artikel
222 ERP abnormalities in schizophrenia prior to neuroleptic treatment Hirayasu, Y.
 1996
 39 7 p. 653-
1 p.
 artikel
223 ERP and behavioral indices of working memory dysfunction in schizophrenia Javitt, D.C.
 1996
 39 7 p. 565-
1 p.
 artikel
224 ERP correlates of recognition memory: Abnormalities in schizophrenia Turetsky, B.
 1996
 39 7 p. 565-
1 p.
 artikel
225 ERP measures of visual spatial processing in schizophrenia O'Donnell, B.F.
 1996
 39 7 p. 655-
1 p.
 artikel
226 ERPS as a probe of language processing difficulties in schizophrenia spectrum disorders Nizniklewicz, M.A.
 1996
 39 7 p. 654-
1 p.
 artikel
227 Evidence for a chromosome 18 bipolar susceptibility locus Berrettini, W.
 1996
 39 7 p. 614-
1 p.
 artikel
228 Evidence for A selective developmental neurocognitive deficit in pediatric OCD Rosenberg, D.
 1996
 39 7 p. 525-
1 p.
 artikel
229 Evidence for linkage of bipolar disorder to HC 18 with a parent-of-origin effect Stine, O.C.
 1996
 39 7 p. 539-
1 p.
 artikel
230 Expression of beta-amyloid precursor protein in the developing rat brain Lahiri, D.K.
 1996
 39 7 p. 589-
1 p.
 artikel
231 Expression of MEF2C by subsets of neocortical and hippocampal neurons Li, Y.L.
 1996
 39 7 p. 585-586
2 p.
 artikel
232 Factor analysis of the dissociative experiences scale in PTSD Amdur, R.
 1996
 39 7 p. 556-
1 p.
 artikel
233 Factors influencing cardiac vagal tone in depressed patients Moser, M.
 1996
 39 7 p. 526-
1 p.
 artikel
234 Factor structure of schizotypy in relatives of schizophrenia patients Bergman, A.
 1996
 39 7 p. 550-
1 p.
 artikel
235 Familial and sporadic schizophrenia show distinct neurobiology Malaspina, D.
 1996
 39 7 p. 550-
1 p.
 artikel
236 Fdopa uptake in schizophrenia: A pet study Potkin, S.G.
 1996
 39 7 p. 604-
1 p.
 artikel
237 Fear-potentiated startle in Vietnam veterans with PTSD Grillon, C.
 1996
 39 7 p. 555-556
2 p.
 artikel
238 Fluoxetine treatment selectively causes brain accumulation of allopregnanolone (allo) Guidotti, A.
 1996
 39 7 p. 592-593
2 p.
 artikel
239 19F magnetic resonance spectroscopy study of fluvoxamine Strauss, W.
 1996
 39 7 p. 517-
1 p.
 artikel
240 Frontal cortex activation increases with working memory load as measured by functional MRI (fMRI) Manoach, D.S.
 1996
 39 7 p. 637-
1 p.
 artikel
241 Functional magnetic resonance imaging and schizophrenia Buckley, P.F.
 1996
 39 7 p. 638-
1 p.
 artikel
242 Functional magnetic resonance studies of brain activation Posse, S.
 1996
 39 7 p. 610-
1 p.
 artikel
243 Functional MRI of effortful attention in humans Breiter, H.C.
 1996
 39 7 p. 636-637
2 p.
 artikel
244 Further development of a neural network for panic disorder Ownby, R.L.
 1996
 39 7 p. 524-
1 p.
 artikel
245 GABA and the pathophysiology of schizophrenia: A neurodevelopmental perspective van Kammen, D.P
 1996
 39 7 p. 507-
1 p.
 artikel
246 GABA-serotonin interactions in healthy subjects: Implications for psychosis Gil, R.
 1996
 39 7 p. 595-596
2 p.
 artikel
247 Gender and neuropsychological function in schizophrenia Smet, I.C.
 1996
 39 7 p. 578-
1 p.
 artikel
248 Gender differences in noradrenergic and serotonergic studies Woo-Ming, A.M.
 1996
 39 7 p. 594-
1 p.
 artikel
249 Genetic analysis of psychosis in portuguese populations Pato, C.N.
 1996
 39 7 p. 540-
1 p.
 artikel
250 Genetic approaches to anorexia nervosa Berrettini, W.
 1996
 39 7 p. 503-
1 p.
 artikel
251 Genetic approaches to elucidate serotonin2A (5HT2A) receptor function Toth, M.
 1996
 39 7 p. 532-
1 p.
 artikel
252 Genetic study of a murine model for opioid addiction Berrettini, W.
 1996
 39 7 p. 542-
1 p.
 artikel
253 Gene variants and treatment response in depression and schizophrenia Ricketts, M.H.
 1996
 39 7 p. 540-
1 p.
 artikel
254 Gonadal steroid levels and memory function in infertile women Soleymani, R.M.
 1996
 39 7 p. 644-
1 p.
 artikel
255 Gray matter and white matter volume loss in anorexia nervosa Zipursky, R.B.
 1996
 39 7 p. 603-
1 p.
 artikel
256 Growth hormone response to sumatriptan (5-HT1D agonist) challenge in sad: Effects of light therapy Yatham, L.N.
 1996
 39 7 p. 617-618
2 p.
 artikel
257 Hallucinogen and other illicit drug uses increases in the USA Johnson, C.R.
 1996
 39 7 p. 628-
1 p.
 artikel
258 Haloperidol attenuates CRF release in the rat: A microdialysis study Forman, S.D.
 1996
 39 7 p. 590-
1 p.
 artikel
259 High-dose versus threshold methods of stimulus dosing in ECT Kumar-Gill, A.
 1996
 39 7 p. 650-
1 p.
 artikel
260 High resolution scatchard analysis of the D1 receptor in the rat medial prefrontal cortex Davidoff, S.A.
 1996
 39 7 p. 631-
1 p.
 artikel
261 High voltage-activated calcium channels: Review and implications for mental illness Black, J.L.
 1996
 39 7 p. 592-
1 p.
 artikel
262 Hippocampal and entophinal hypoplasia in schizophrenia is associated with early onset Nasrallah, H.A.
 1996
 39 7 p. 599-
1 p.
 artikel
263 Hippocampal gating of cortical throughput in the nucleus accumbens: Modulation by dopamine O’Donnell, P.
 1996
 39 7 p. 632-
1 p.
 artikel
264 1H MRS investigation of panic disorder Dager, S.R.
 1996
 39 7 p. 609-
1 p.
 artikel
265 Hormone stimulation of catecholamine innervation in primate prefrontal cortex Kritzer, M.F.
 1996
 39 7 p. 590-
1 p.
 artikel
266 How neurons die Coyle, J.T.
 1996
 39 7 p. 611-
1 p.
 artikel
267 HPLC determination of agmatine in rat brain and human plasma Halaris, A.E.
 1996
 39 7 p. 582-583
2 p.
 artikel
268 HPT and HPA axis dysfunction in depression: DA, NA, and 5HT correlates Duval, F.
 1996
 39 7 p. 643-
1 p.
 artikel
269 5-HT1A, MR and GR gene expression in the hippocampus of suicide victims López, J.F.
 1996
 39 7 p. 538-539
2 p.
 artikel
270 5-HT1A receptor sensitivity after 5-HT2A receptor downregulation Hensler, J.G.
 1996
 39 7 p. 533-
1 p.
 artikel
271 [3H]WIN 35428 and [125I]RTI-55 binding to wild type and mutant dopamine transporter Little, K.Y.
 1996
 39 7 p. 633-
1 p.
 artikel
272 Hyperactivation of the HPT axis in depression-new evidence Mourilhe, P.R.
 1996
 39 7 p. 647-
1 p.
 artikel
273 Hypercortisolemia and cognitive dysfunction in schizophrenia Huang, G.
 1996
 39 7 p. 552-
1 p.
 artikel
274 Hypofrontality in drug-free schizophrenic patients revealed by EEG coherence analysis Tauscher, J.
 1996
 39 7 p. 657-
1 p.
 artikel
275 Hypofrontality in major depressive disorder: Relationship to psychiatric symptoms Galynker, I.
 1996
 39 7 p. 603-
1 p.
 artikel
276 IBZM SPECT measurement of D2 receptor occupancy by haloperidol and risperidone Knable, M.B.
 1996
 39 7 p. 515-
1 p.
 artikel
277 IBZM-SPECT shows low striatal D2 blockade under therapy with seroquel Tauscher, J.
 1996
 39 7 p. 514-515
2 p.
 artikel
278 Identification of OCD subtypes Leckman, J.F.
 1996
 39 7 p. 508-
1 p.
 artikel
279 Imaging memory systems in the normal human brain Raichle, M.E.
 1996
 39 7 p. 608-
1 p.
 artikel
280 Immune dysfunction in affective subtypes Hornig-Rohan, M.
 1996
 39 7 p. 524-
1 p.
 artikel
281 Impact of a high intensity, easy access ambulatory program for bipolar disorder Bauer, M.
 1996
 39 7 p. 527-528
2 p.
 artikel
282 Improvement in working memory in schizotypal subjects following physostigmine Callahan, A.M.
 1996
 39 7 p. 570-
1 p.
 artikel
283 Incidence of suicide in a research study of first episode schizophrenia Mendelowitz, A.
 1996
 39 7 p. 521-
1 p.
 artikel
284 Increased genetic liability to schizophrenia-spectrum disorders in first degree relatives of neuroleptic-resistant schizophrenic patients Joober, R.
 1996
 39 7 p. 550-
1 p.
 artikel
285 Increased striatal dopamine release in drug free schizophrenic subjects Laruelle, M.
 1996
 39 7 p. 560-
1 p.
 artikel
286 Individual differences in cortical and subcortical GABAA binding and behavior Gruen, R.J.
 1996
 39 7 p. 616-
1 p.
 artikel
287 Information processing impairment: A clinical & neurodevelopmental perspective Braff, D.L.
 1996
 39 7 p. 501-
1 p.
 artikel
288 Instrumental assessment of longitudinal variations in tardive dyskinesia Stanilla, J.K.
 1996
 39 7 p. 548-
1 p.
 artikel
289 Intermittent low dose clozapine sensitizes (kindles?) myoclonus Denney, D.
 1996
 39 7 p. 531-
1 p.
 artikel
290 In vitro agonists reverse neuroleptic induced decline in PCP site binding McCoy, L.
 1996
 39 7 p. 586-
1 p.
 artikel
291 In vivo brain pet responses and neuroendocrine alterations following serotonin release in depressed patients versus healthy controls Malone, K.M.
 1996
 39 7 p. 517-
1 p.
 artikel
292 In vivo proton MRS of Alzheimer's Disease in the parietal and temporal lobes Frederick, B.deS.
 1996
 39 7 p. 658-
1 p.
 artikel
293 Is circadian variation of plasma HVA related to its renal excretion? Stroe, A.
 1996
 39 7 p. 633-
1 p.
 artikel
294 Isolation-reared macaques are hyposensitive to stimuli in a two-bottle choice paradigm Paul, I.A.
 1996
 39 7 p. 525-
1 p.
 artikel
295 Is post stress HPA response prolonged (Disinhibited) in aged humans? Stokes, P.E.
 1996
 39 7 p. 554-
1 p.
 artikel
296 Ketanserin binding characteristics to 5-HT2A receptor: Evidence for two binding subsites Gurguis, G.N.M.
 1996
 39 7 p. 534-
1 p.
 artikel
297 Kinase-dependent spontaneous activity of G protein-coupled receptors Deth, R.C.
 1996
 39 7 p. 581-582
2 p.
 artikel
298 Landmark shepe in schizophrenia: Regional neuroanatomic correlates DeQuardo, J.R.
 1996
 39 7 p. 600-
1 p.
 artikel
299 Latent structure of the hamilton depression rating scale in major depressive disorder Cai, J.
 1996
 39 7 p. 523-524
2 p.
 artikel
300 Late-onset schizophrenia Jeste, D.V.
 1996
 39 7 p. 510-
1 p.
 artikel
301 Late paraphrenia, past and present Roth, M.
 1996
 39 7 p. 511-
1 p.
 artikel
302 Lateral and medial temporal Lobe metabolic rate in Alzheimer's disease Shihabuddin, L.
 1996
 39 7 p. 660-
1 p.
 artikel
303 Learning social skills in psychotic patients: Gender effects Smith, T.E.
 1996
 39 7 p. 552-
1 p.
 artikel
304 Linkage studies in Irish Highdensity Schizophrenfa Families Kendler, K.S.
 1996
 39 7 p. 614-
1 p.
 artikel
305 Linkage studies of bipolar disorder to chromosome 18 markers Nothen, M.M.
 1996
 39 7 p. 615-
1 p.
 artikel
306 Lithium and carbamazepine differentially affect locomotion and camp binding stimulated by cholera toxin Kofman, O
 1996
 39 7 p. 594-595
2 p.
 artikel
307 Longitudinal neuropsychological change in first-episode schizophrenia Goldman, R.S.
 1996
 39 7 p. 520-
1 p.
 artikel
308 Long term behavioral and neurochemical changes after isolation rearing in rats Bakshi, V.P.
 1996
 39 7 p. 555-
1 p.
 artikel
309 Loss of cerebral asymmetry in familial schizophrenia, a volumetric study using unbiased stereology Sharma, T.
 1996
 39 7 p. 602-
1 p.
 artikel
310 Lower level of estradiol in postpartum depression among Chinese women Lui, R.B.
 1996
 39 7 p. 648-
1 p.
 artikel
311 Lumped constant for pharmacokinetic estimation of brain serotonin synthesis rates Shoaf, J.F.
 1996
 39 7 p. 533-
1 p.
 artikel
312 Lymphocyte phospholipid methylation is altered in schizophrenia Deth, R.C.
 1996
 39 7 p. 504-505
2 p.
 artikel
313 Magnesium sulphate has GABA-Agonistic effects on sleep in healthy men Murck, H.
 1996
 39 7 p. 591-
1 p.
 artikel
314 Magnetic resonance imaging in schizophrenia Yurgelun-Todd, D.A.
 1996
 39 7 p. 559-
1 p.
 artikel
315 Magnetic resonance spectroscopic inestigations of affective disorders Kato, T.
 1996
 39 7 p. 609-
1 p.
 artikel
316 Maintenance treatment for obsessive-compulsive disorder Hollander, E.
 1996
 39 7 p. 610-
1 p.
 artikel
317 Maintenance treatment for panic disorder Gorman, J.M.
 1996
 39 7 p. 610-
1 p.
 artikel
318 Maintenance treatment for schizophrenia Kane, J.
 1996
 39 7 p. 610-
1 p.
 artikel
319 Maintenance treatment in older schizophrenics Harris, M.J.
 1996
 39 7 p. 510-
1 p.
 artikel
320 Mechanism of efficacy of fluoxetine in premenstrual syndrome Roca, C.A.
 1996
 39 7 p. 646-
1 p.
 artikel
321 Mechanism of sexual dysfunction in alcohol dependence: A pudendal sep study Cheon, J.S.
 1996
 39 7 p. 626-
1 p.
 artikel
322 Mechanisms of auditory working memory dysfunction in schizophrenia Shelley, A.M.
 1996
 39 7 p. 655-
1 p.
 artikel
323 Mechanisms of selective attention in schizophrenia Barch, D.M.
 1996
 39 7 p. 579-580
2 p.
 artikel
324 Menstrual cycle effects on the auditory brainstem response Tasman, A.
 1996
 39 7 p. 645-
1 p.
 artikel
325 Mesostriatal, mesolimbic and mesocortical dopamine neurons in primates Williams, S.M.
 1996
 39 7 p. 629-630
2 p.
 artikel
326 Metabolic patterns associated with depressive symptoms in schizophrenia Kohler, C.
 1996
 39 7 p. 604-
1 p.
 artikel
327 Methods for planum temporale measurement: Their importance for schizophrenia Barta, P.
 1996
 39 7 p. 638-639
2 p.
 artikel
328 Methyl donation by D4 dopamine receptors in phospholipid methylation Deth, R.C.
 1996
 39 7 p. 631-
1 p.
 artikel
329 Methylphenidate effects on verbal fluency in schizophrenia Szeszko, P.R.
 1996
 39 7 p. 576-
1 p.
 artikel
330 Metrifonate, physostigmine and tacrine: Effects on the processing of βAPP Lahiri, D.K.
 1996
 39 7 p. 588-
1 p.
 artikel
331 Migraine and the contents of tyramine and phenylethylamine in food Mosnaim, A.D.
 1996
 39 7 p. 595-
1 p.
 artikel
332 MK-801 differentially regulates dopamine receptor mRNA in hippocampus Healy, D.J.
 1996
 39 7 p. 633-
1 p.
 artikel
333 Molecular genetics of impaired impulse control and early onset alcoholism Goldman, D.
 1996
 39 7 p. 561-
1 p.
 artikel
334 Molecular genetic studies in affective disorders Mendlewicz, J.
 1996
 39 7 p. 564-
1 p.
 artikel
335 Molecular strategies for identifying the roles of steroids in behavior Pfaff, D.
 1996
 39 7 p. 502-503
2 p.
 artikel
336 Monoamines, personality, and early-onset alcoholism Cloninger, C.R.
 1996
 39 7 p. 560-561
2 p.
 artikel
337 Mood and reproductive hormones, an overview Halbreich, U.
 1996
 39 7 p. 612-613
2 p.
 artikel
338 Mood disorder phenotype in affected SIB pairs sharing paternal alleles at D18S41 McMahon, F.J.
 1996
 39 7 p. 539-540
2 p.
 artikel
339 MRI volume and localization of Heschl's gyri in schizophrenia Reite, M.
 1996
 39 7 p. 639-
1 p.
 artikel
340 MRS: At the edge of pharmacotherapeutics? Karson, C.N.
 1996
 39 7 p. 560-
1 p.
 artikel
341 Negative symptoms improve in deficit and nondeficit schizophrenia Tandon, R.
 1996
 39 7 p. 545-
1 p.
 artikel
342 Negative symptoms in medical and surgical patients undergoing intensive rehabilitation Galynker, I.
 1996
 39 7 p. 663-664
2 p.
 artikel
343 Neural mechanisms underlying alcohol's reinforcing properties Ownby, R.L.
 1996
 39 7 p. 627-
1 p.
 artikel
344 Neural network model successfully predicts amphetamine effects in new task Servan-Schreiber, D.
 1996
 39 7 p. 512-
1 p.
 artikel
345 Neural substrates of eye tracking deficits in relatives of schizophrenics O’Driscoll, G.A.
 1996
 39 7 p. 573-
1 p.
 artikel
346 Neural systems underlying learning and memory Damasio, A.R.
 1996
 39 7 p. 608-
1 p.
 artikel
347 Neuroactive steroids Paul, S.M.
 1996
 39 7 p. 502-
1 p.
 artikel
348 Neurobiological mechanisms of relapse Self, D.W.
 1996
 39 7 p. 508-
1 p.
 artikel
349 Neurodegeneration in schizophrenia: A possible animal model? Bardgett, M.E.
 1996
 39 7 p. 611-612
2 p.
 artikel
350 Neuroendocrine abnormalities in psychiatric patients: A multivariate study Duval, F.
 1996
 39 7 p. 642-
1 p.
 artikel
351 Neuroendocrine correlates of antipsychotic response in schizophrenia Duval, F.
 1996
 39 7 p. 642-
1 p.
 artikel
352 Neuroendocrine-immune interactions in the every day life of healthy volunteers Kronfol, Z.
 1996
 39 7 p. 647-648
2 p.
 artikel
353 Neuroendocrine responses to the citalopram challenge test in depression Kapitany, T.
 1996
 39 7 p. 647-
1 p.
 artikel
354 Neuroendocrinological impacts of glucoprivic stress Elman, I.
 1996
 39 7 p. 645-
1 p.
 artikel
355 Neuroleptic dosing with inpatient hispanic and asian schizophrenics Herrera, J.
 1996
 39 7 p. 599-
1 p.
 artikel
356 Neuroleptic dosing with outpatient hispanic and asian schizophrenics Herrera, J.
 1996
 39 7 p. 599-
1 p.
 artikel
357 Neuroleptic effects on the respiratory chain Higgins Jr., D.S.
 1996
 39 7 p. 553-
1 p.
 artikel
358 Neuroleptics as antagonists and agonists of neurotransmitter receptors Richelson, E.
 1996
 39 7 p. 557-558
2 p.
 artikel
359 Neurological soft signs, negative symptoms, and flat affect Smith, R.C.
 1996
 39 7 p. 546-
1 p.
 artikel
360 Neuropsychological assessments in detoxified alcoholics Chung, I.W.
 1996
 39 7 p. 627-
1 p.
 artikel
361 Neuropsychological correlates of prefrontal volume in schizophrenia Lencz, T.
 1996
 39 7 p. 579-
1 p.
 artikel
362 Neuropsychological deficits in marijuana smokers Yurgelun-Todd, D.A.
 1996
 39 7 p. 616-
1 p.
 artikel
363 Neuropsychological measures of prefrontal dysfunction in schizophrenia Seidman, L.J.
 1996
 39 7 p. 578-
1 p.
 artikel
364 Neuropsychological probes of prefrontal dysfunction in schizophrenia Kremen, W.S.
 1996
 39 7 p. 578-579
2 p.
 artikel
365 Neurosurgical procedures for refractory OCD Jenike, M.A.
 1996
 39 7 p. 511-
1 p.
 artikel
366 Neurotensin and metabolites in CSF of patients with schizophrenia and controls Butler, P.D.
 1996
 39 7 p. 587-
1 p.
 artikel
367 New indices of serotonin function and their relationship to impulsivity Reist, C.
 1996
 39 7 p. 534-
1 p.
 artikel
368 Nicotine withdrawal and psychiatric symptoms in smokers with schizophrenia Dalack, G.W.
 1996
 39 7 p. 547-
1 p.
 artikel
369 NMDA receptor function and schizophrenia: Studies with ketamine Malhotra, A.K.
 1996
 39 7 p. 586-
1 p.
 artikel
370 Nocturnal oxytocin secretion is reduced in major depression Zetzsche, T.
 1996
 39 7 p. 584-
1 p.
 artikel
371 Noradrenergic and thyroid axis dysfunction in depression Duval, F.
 1996
 39 7 p. 643-
1 p.
 artikel
372 Notices 1996
 39 7 p. viii-ix
nvt p.
 artikel
373 Oculomotor. Cognitive and subjective effects of ketamine in normals Roy-Byrne, P.
 1996
 39 7 p. 574-
1 p.
 artikel
374 Olfactory functioning in siblings discordant for schizophrenia Moberg, P.J.
 1996
 39 7 p. 571-572
2 p.
 artikel
375 Olfactory sensitivity in eating disorders Sirota, P.
 1996
 39 7 p. 572-
1 p.
 artikel
376 Ondansetron in social phobia Grunes, M.S.
 1996
 39 7 p. 624-
1 p.
 artikel
377 One-year outcome in deficit and nondeficit schizophrenia Goldman, M.
 1996
 39 7 p. 545-
1 p.
 artikel
378 Optimal haloperidol dosage for first episode schizophrenia Wong, J.
 1996
 39 7 p. 513-
1 p.
 artikel
379 Organization and development of the embryonic forebrain Rubenstein, J.L.R.
 1996
 39 7 p. 557-
1 p.
 artikel
380 Orienting response in schizophrenia and mania: Neuropsychological testing Schnur, D.B.
 1996
 39 7 p. 581-
1 p.
 artikel
381 Overlap of negative and depressive symptoms in non-schizophrenic subjects Galynker, I.
 1996
 39 7 p. 543-
1 p.
 artikel
382 Oxytocin effects on ampa receptor mRNA regulation in hippocampus Karm-Hage, M.
 1996
 39 7 p. 593-594
2 p.
 artikel
383 Pain perception in self-injurious borderline patients Kemperman, I.
 1996
 39 7 p. 537-538
2 p.
 artikel
384 Panic disorder is unlikely to be a homogeneous autosomal dominant disorder: Results of a genome-wide genetic screen Knowles, J.A.
 1996
 39 7 p. 567-
1 p.
 artikel
385 Paradoxical invigoration through sleep deprivation Szuba, M.P.
 1996
 39 7 p. 622-623
2 p.
 artikel
386 Parkinsonism in drug-naive first-episode schizophrenic patients Scheffer, R.E.
 1996
 39 7 p. 520-521
2 p.
 artikel
387 PDG-PET predictors of response to behavioral versus pharmacotherapy in OCD Brody, A.L.
 1996
 39 7 p. 517-518
2 p.
 artikel
388 Persistent respiratory irregularity in patients with panic disorder Abelson, J.L.
 1996
 39 7 p. 521-522
2 p.
 artikel
389 PET findings in differential OCD treatment response Baxter, L.R.
 1996
 39 7 p. 560-
1 p.
 artikel
390 Pharmacology of ‘Seroquel’ (ICI 204,636): An atypical clozapine-like antipsychotic Goldstein, J.M.
 1996
 39 7 p. 598-
1 p.
 artikel
391 Phenotype of depression in Alzheimer's disease (AD) with APOE genotype Cantillon, M.
 1996
 39 7 p. 661-
1 p.
 artikel
392 Phosphorous-31 magnetic resonance spectroscopy of the basal ganglia in depressed subjects Moore, C.M.
 1996
 39 7 p. 635-636
2 p.
 artikel
393 Plasma fatty acids predict CSF 5-HIAA and HVA in normals, early and late onset alcoholics Hibbeln, J.R.
 1996
 39 7 p. 536-
1 p.
 artikel
394 Plasticity and cognitive disorders Gazzaniga, M.S.
 1996
 39 7 p. 607-
1 p.
 artikel
395 P300 latency and cortical tissue volume in alcoholics Ford, J.M.
 1996
 39 7 p. 565-
1 p.
 artikel
396 Polysomnographic abnormalities in schizophrenia: A replication Maixner, S.
 1996
 39 7 p. 552-
1 p.
 artikel
397 Portable device for quantitative measurement of motor symptoms Lim, K.O.
 1996
 39 7 p. 548-
1 p.
 artikel
398 Positive symptoms in dopamincrgic psychosis—implications for the dopamine hypothesis of schizophrenia Heinz, A.
 1996
 39 7 p. 544-
1 p.
 artikel
399 Post-operative mental status changes following anesthesia in children Martini, D.R.
 1996
 39 7 p. 663-
1 p.
 artikel
400 Post-traumatic stress disorder: A developmental perspective Putnam, F.
 1996
 39 7 p. 507-
1 p.
 artikel
401 Power spectrum of the QRS complex: Comparison of patients with panic disorder and controls Yeragani, V.
 1996
 39 7 p. 522-
1 p.
 artikel
402 Predicting clinical response to clozapine treatment by plasma level Bera, R.
 1996
 39 7 p. 529-
1 p.
 artikel
403 Predictive and visually-guided saccades in obsessive-compulsive disorder Farber, R.H.
 1996
 39 7 p. 573-
1 p.
 artikel
404 Prefrontal-thalamic network for sensory gating in normal individuals Hazlett, B.A.
 1996
 39 7 p. 605-
1 p.
 artikel
405 Premorbid dysfunction in schizophrenia: Nature and progression Gribbin, D.
 1996
 39 7 p. 546-
1 p.
 artikel
406 Prevalence of DSM-IV mood disorders in the general population of UK Ohayon, M.M.
 1996
 39 7 p. 664-
1 p.
 artikel
407 Prevalence of psychotropic drug consumption in the general population of UK Ohayon, M.M.
 1996
 39 7 p. 665-
1 p.
 artikel
408 Probable neuroleptic induced tardive dyskinesia in association with combined fluoxetine and risperidone treatment Daniel, D.G.
 1996
 39 7 p. 553-
1 p.
 artikel
409 Problems in post-mortem diagnosis can be solved Bigelow, L.B.
 1996
 39 7 p. 596-
1 p.
 artikel
410 Processing negativity in schizotypal university students Roth, R.M.
 1996
 39 7 p. 654-655
2 p.
 artikel
411 Program 1996
 39 7 p. 467-499
33 p.
 artikel
412 Progress in epilepsy: Psychiatric and psychopharmacologic advances Chapman, D.P.
 1996
 39 7 p. 662-663
2 p.
 artikel
413 Progress in the search for schizophrenia susceptibility genes Moises, H.W.
 1996
 39 7 p. 615-
1 p.
 artikel
414 Prolactin response to ect: Effects of electrode placement and dosage Lisanby, S.H.
 1996
 39 7 p. 649-
1 p.
 artikel
415 Proton magnetic resonance spectroscopic imaging in a monkey model of schizophrenia: Preliminary results Bertolino, A.
 1996
 39 7 p. 635-
1 p.
 artikel
416 Proton magnetic resonance spectroscopic imaging in drug free patients with schizophrenia: Regional neuronal damage Bertolino, A.
 1996
 39 7 p. 634-
1 p.
 artikel
417 Proton magnetic resonance study of the hippocampus in schizophrenia Kegeles, L.S.
 1996
 39 7 p. 635-
1 p.
 artikel
418 Proton MRS of human basal ganglia during acute cocaine administration Christensen, J.D.
 1996
 39 7 p. 609-610
2 p.
 artikel
419 P300 subcomponent abnormalities in siblings discordant for schizophrenia Turetsky, B.
 1996
 39 7 p. 654-
1 p.
 artikel
420 Psychiatric correlates of EEG asymmetries in major depression Lee, G.P.
 1996
 39 7 p. 656-
1 p.
 artikel
421 Putative endogenous anxiogens and anxiolytics Lapin, I.P.
 1996
 39 7 p. 563-564
2 p.
 artikel
422 Quantitative neuroanatomic study of schizophrenia: Landmark-based analysis DeQuardo, J.R.
 1996
 39 7 p. 601-
1 p.
 artikel
423 Questionable dementia: Clinical course and predictors of outcome Devanand, D.P.
 1996
 39 7 p. 662-
1 p.
 artikel
424 Rapid transcranial magnetic stimulation (RTMS)—A potential new neuropsychiatric treatment George, M.S.
 1996
 39 7 p. 512-
1 p.
 artikel
425 Rat dorsal raphe 5-HT1B receptor MRNA is differentially regulated by fluoxetine and learned helplessness Neumaier, J.F.
 1996
 39 7 p. 533-
1 p.
 artikel
426 rCBF changes in OCD patients receiving antidepressants Hoehn-Saric, R.
 1996
 39 7 p. 515-516
2 p.
 artikel
427 rCBF changes with clozapine treatment in refractory bipolar disorder Trivedi, M.H.
 1996
 39 7 p. 531-
1 p.
 artikel
428 Recent biological research trends in the institute of mental health of BMU Shen, Y.-C.
 1996
 39 7 p. 563-
1 p.
 artikel
429 Recognition of facial expression and emotional prosody in schizophrenia Shaw, R.J.
 1996
 39 7 p. 578-
1 p.
 artikel
430 Reduced blue cone ERG in cocaine patients Roy, A.
 1996
 39 7 p. 626-
1 p.
 artikel
431 Reduced heart rate response to nortriptyline in females with unipolar depression Pomara, N.
 1996
 39 7 p. 624-
1 p.
 artikel
432 Reduced long-latency positive activity in schizophrenia on a homograph task Salisbury, D.F.
 1996
 39 7 p. 653-654
2 p.
 artikel
433 Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients Seidman, L.J.
 1996
 39 7 p. 602-
1 p.
 artikel
434 Regional cerebral blood flow in patients with dementia of Alzheimer's type: Relationship to psychiatric symptoms Galynker, I.
 1996
 39 7 p. 659-
1 p.
 artikel
435 Regulation of adenosine- and G protein-mediated signalling in opiate dependence Kaplan, G.B.
 1996
 39 7 p. 505-
1 p.
 artikel
436 Regulation of hippocampal dopamine receptors by clozapine and haloperidol Ritter, L.M.
 1996
 39 7 p. 629-
1 p.
 artikel
437 Regulation of platelet serotonin transporter by protein kinase C Marazziti, D.
 1996
 39 7 p. 532-
1 p.
 artikel
438 Relapse prevention strategies in the treatment of alcoholism O’Malley, S.S.
 1996
 39 7 p. 611-
1 p.
 artikel
439 Relationship between spectral characteristics of resting EEG and P50 gating Light, G.A.
 1996
 39 7 p. 656-
1 p.
 artikel
440 Release and inactivation of endogenous cannabinoid substances Piomelli, D.
 1996
 39 7 p. 615-616
2 p.
 artikel
441 Relevance of EEG manifestations during electroconvulsive therapy Maixner, D.
 1996
 39 7 p. 650-
1 p.
 artikel
442 Reliability of a non-invasive [11C]-Raclopride scan to measure D2-Dopamine receptors Jones, C.L.
 1996
 39 7 p. 515-
1 p.
 artikel
443 Reproducibility of plasma catecholamine metabolites in normal subjects Hashmi, A.
 1996
 39 7 p. 593-
1 p.
 artikel
444 Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia and normal controls Bertolino, A.
 1996
 39 7 p. 634-635
2 p.
 artikel
445 Reproductive hormones and mood in women Rubinow, D.R.
 1996
 39 7 p. 613-
1 p.
 artikel
446 Reproductive hormones as adjuncts to psychotropic medications Stahl, S.M.
 1996
 39 7 p. 613-
1 p.
 artikel
447 Resonance and positron emission tomography Andreasen, N.C.
 1996
 39 7 p. 559-
1 p.
 artikel
448 Respiratory sinus arrhythmia in schizophrenia and mania Smith, S.
 1996
 39 7 p. 553-
1 p.
 artikel
449 Reversed planum temporale asymmetry in schizophrenia — Replication study Pearlson, G.
 1996
 39 7 p. 637-638
2 p.
 artikel
450 Risk and protective factors across the schizophrenia spectrum Siever, L.J.
 1996
 39 7 p. 501-
1 p.
 artikel
451 Role of ovarian steroids in modulating mood in premenstrual syndrome Schechter, D.
 1996
 39 7 p. 646-
1 p.
 artikel
452 Roles of metabotropic glutamate receptors in the hippocampus Conn, P.J.
 1996
 39 7 p. 558-
1 p.
 artikel
453 Rolipram, a phosphodiesterase inhibitor, facilitates late phase LTP and improves memory Barad, M.
 1996
 39 7 p. 571-
1 p.
 artikel
454 Schizophrenia and affective disorders after prenatal famine Brown, A.S.
 1996
 39 7 p. 551-
1 p.
 artikel
455 Schizophrenia, borna disease, and neurological signs in a monozygotic twin study cohort Waltrip, R.W.
 1996
 39 7 p. 544-
1 p.
 artikel
456 Schizophrenia loci: Data of the JHU collaborative group Pulver, A.
 1996
 39 7 p. 614-
1 p.
 artikel
457 Schizophrenic disorders: Neurodevelopmental and onset vulnerability factors McCarley, R.W.
 1996
 39 7 p. 502-
1 p.
 artikel
458 Schizophrenic spatial working memory: Neuropsychological correlates Levitt, J.J.
 1996
 39 7 p. 570-
1 p.
 artikel
459 Schizophrenic symptoms and specific regions of prefrontal Wible, C.G.
 1996
 39 7 p. 543-544
2 p.
 artikel
460 Schizotypal personality disorder: A MRI analysis of the whole brain Dickey, C.C.
 1996
 39 7 p. 602-
1 p.
 artikel
461 Scopolamine effects on rCBF during human eyeblink conditioning Bahro, M.
 1996
 39 7 p. 516-517
2 p.
 artikel
462 Seasonal variation of suicide in south africa Flisher, A.J.
 1996
 39 7 p. 522-523
2 p.
 artikel
463 Selective pharmacological limbic activation: Phenomenology and blood-flow Servan-Schreiber, D.
 1996
 39 7 p. 608-
1 p.
 artikel
464 Self-injury: Progress in the understanding of an intractable behavior Tuinier, S.
 1996
 39 7 p. 521-
1 p.
 artikel
465 Self-reported abuse and biological measures in personality disorders New, A.S.
 1996
 39 7 p. 535-
1 p.
 artikel
466 Sensory gating in a computer model of the CA3 neural network of the hippocampus Flach, K.A.
 1996
 39 7 p. 630-
1 p.
 artikel
467 Sequential studies of the treatment of mania Small, J.G.
 1996
 39 7 p. 618-
1 p.
 artikel
468 ‘Seroquel’ (ICI 204,636): Not different from placebo for EPS of prolactin Hong, W.W.
 1996
 39 7 p. 598-
1 p.
 artikel
469 Serotonin function and vulnerability to depression Miller, H.L.
 1996
 39 7 p. 528-
1 p.
 artikel
470 Serum cholesterol and impulsive aggressive behavior in personality disorder patients Zale, C.
 1996
 39 7 p. 535-
1 p.
 artikel
471 Sex differences in olfactory identification & WCST performance in schizophrenia Seidman, L.J.
 1996
 39 7 p. 574-
1 p.
 artikel
472 Sex differences in pet fdopa uptake Klein, E.A.
 1996
 39 7 p. 604-
1 p.
 artikel
473 Sex differences in the response to pharmacotherapy among early onset dysthymics Yonkers, K.A.
 1996
 39 7 p. 625-
1 p.
 artikel
474 Sibling resemblance for depression in a high-risk sample of adults Rende, R.
 1996
 39 7 p. 528-
1 p.
 artikel
475 Side effect profile of Venlafaxine in children and adolescents Mandoki, M.
 1996
 39 7 p. 621-
1 p.
 artikel
476 Simulation for desensitization of children requiring MRI Rosenberg, D.
 1996
 39 7 p. 664-
1 p.
 artikel
477 Sleep endocrine effects of neuropeptide (NPY) in men reveal a GABAA-agonistic action Antonijevic, I.A.
 1996
 39 7 p. 643-644
2 p.
 artikel
478 Smooth pursuit eye movements after smoking in schizophrenic patients Olincy, A.
 1996
 39 7 p. 574-
1 p.
 artikel
479 Society information 1996
 39 7 p. v-vii
nvt p.
 artikel
480 Specific hippocampal atrophy identifies early Alzheimer's dementia Convit, A.
 1996
 39 7 p. 658-
1 p.
 artikel
481 Steroid effects on cell membrane structure: Implications for depressive illness Mason, R.P.
 1996
 39 7 p. 585-
1 p.
 artikel
482 Stress — Restress: An animal model of HPA abnormalities in PTSD Liberzon, I.
 1996
 39 7 p. 567-
1 p.
 artikel
483 Stroop performance in first degree relatives of schizophrenic patients Yurgelun-Todd, D.A.
 1996
 39 7 p. 568-569
2 p.
 artikel
484 Study of HLA-DRB1 genotyping in schizophrenia in Japanese Fujimoto, T.
 1996
 39 7 p. 541-
1 p.
 artikel
485 Substance abuse and the course of schizophrenia Turner, W.M.
 1996
 39 7 p. 551-552
2 p.
 artikel
486 Suicidal ideation and behavior in recent-onset schizophrenia Young, A.S.
 1996
 39 7 p. 521-
1 p.
 artikel
487 Suicidal states in children, adolescents, and young adults Pfeffer, C.
 1996
 39 7 p. 507-508
2 p.
 artikel
488 Surgical therapies for parkinson's disease: Embryonic nigral grafts and pallidal ablation Eidelberg, D.
 1996
 39 7 p. 511-
1 p.
 artikel
489 Sweet liking/novelty seeking interactions predict a diagnosis of alcoholism Janowsky, D.
 1996
 39 7 p. 628-
1 p.
 artikel
490 Synapsin isoforms from primitive vertebrates: Evolutionary and functional significance Kao, H.-T.
 1996
 39 7 p. 594-
1 p.
 artikel
491 Tardive dyskinesia, clozapine and treatment response Dalack, G.W.
 1996
 39 7 p. 530-
1 p.
 artikel
492 Targeted disruptioin of the mouse RPX gene Feltner, D.E.
 1996
 39 7 p. 542-
1 p.
 artikel
493 Temporal lobe changes distinguish schizophrenia from bipolar disorder Pearlson, G.
 1996
 39 7 p. 638-
1 p.
 artikel
494 Temporal lobe structure angulation in first-episode schizophrenia Wu, H.
 1996
 39 7 p. 519-
1 p.
 artikel
495 Test-retest stability of the neurologic examination in schizophrenia Sanders, R.D.
 1996
 39 7 p. 548-
1 p.
 artikel
496 The association of cognitive performance with quality of life in schizophrenia Swanson Jr., C.L.
 1996
 39 7 p. 546-
1 p.
 artikel
497 The corpus callosum in childhood onset schizophrenia Jacobsen, L.K.
 1996
 39 7 p. 518-519
2 p.
 artikel
498 The dementia of schizophrenia: Antemortem and postmortem studies Gur, R.E.
 1996
 39 7 p. 612-
1 p.
 artikel
499 The effect of amyloid precursor protein and presenilin mutations on amyloid beta protein Younkin, S.G.
 1996
 39 7 p. 562-
1 p.
 artikel
500 The effect of catecholamine depletion on thyrotropin secretion Krahn, L.E.
 1996
 39 7 p. 592-
1 p.
 artikel
501 The effect of naltrexone on diazepam intoxication in social drinkers Swift, R.M.
 1996
 39 7 p. 628-
1 p.
 artikel
502 The effect of neuroleptic drugs on olfactory sensitivity in schizophrenia Sirota, P.
 1996
 39 7 p. 551-
1 p.
 artikel
503 The effect of substance abuse on the course of bipolar disorder Dunner, D.L.
 1996
 39 7 p. 617-
1 p.
 artikel
504 The effect of the CCK-B receptor antagonist CI-988 on CCK-4 induced panic attacks van Megen, H.J.G.M.
 1996
 39 7 p. 625-626
2 p.
 artikel
505 The effects of clozapine on sleep EEG in bipolar illness Armitage, R.
 1996
 39 7 p. 657-
1 p.
 artikel
506 The effects of clozapine on symptom clusters in older “treatment-refractory” patients Abraham, G.
 1996
 39 7 p. 543-
1 p.
 artikel
507 The effects of clozapine treatment on auditory event-related potentials (aERP) Umbricht, D.
 1996
 39 7 p. 652-653
2 p.
 artikel
508 The effects of distracter stimuli upon saccade latency in schizophrenics Schwartz, B.D.
 1996
 39 7 p. 573-
1 p.
 artikel
509 The effects of metabolic and cognitive stress on cerebral blood flow Elman, I.
 1996
 39 7 p. 604-605
2 p.
 artikel
510 The effects of risperidone vs. haloperidol on spatial working memory in treatment-resistant schizophrema McGurk, S.R.
 1996
 39 7 p. 571-
1 p.
 artikel
511 The “high risk” paradigm: Childhood predictors of schizophrenic disorders Cornblatt, B.A.
 1996
 39 7 p. 500-501
2 p.
 artikel
512 The impact of sex on cognition and structural brain MRI in schizophrenia Goldstein, J.M.
 1996
 39 7 p. 575-
1 p.
 artikel
513 The influence of ECT on olfactory memory Sirota, P.
 1996
 39 7 p. 571-
1 p.
 artikel
514 The influence of “silent” cerebrovascular disease on measurement in Alzheimer's disease Lawlor, B.A.
 1996
 39 7 p. 659-
1 p.
 artikel
515 The motor agitation and retardation scale: Item analysis and inter-rater reliability Sobin, C.
 1996
 39 7 p. 523-
1 p.
 artikel
516 The myers briggs type indicator and psychiatric diagnosis Janowsky, D.
 1996
 39 7 p. 527-
1 p.
 artikel
517 The neurobiology of eating disorders Leibowitz, S.F.
 1996
 39 7 p. 503-
1 p.
 artikel
518 The parietal lobes in schizophrenia: A quantitative MR study Donnino, R.
 1996
 39 7 p. 639-
1 p.
 artikel
519 The prediction of alcoholism a decade later Schuckit, M.A.
 1996
 39 7 p. 617-
1 p.
 artikel
520 The prevalence of PTSD among car accident victims: A prospective study Klein, E.
 1996
 39 7 p. 554-555
2 p.
 artikel
521 The relationship between clozapine dose and plasma level and side effects Kalali, A.H.
 1996
 39 7 p. 529-
1 p.
 artikel
522 The relationship of prolactin to tardive dyskinesia and psychosis in treatment-resistant schizophrenia Verghese, C.
 1996
 39 7 p. 528-
1 p.
 artikel
523 The role of GHRH in normal and pathological sleep regulation Steiger, A.
 1996
 39 7 p. 643-
1 p.
 artikel
524 The role of the serotonergic system in seasonal affective disorder Neumeister, A.
 1996
 39 7 p. 623-624
2 p.
 artikel
525 The startle reflex is facilitated by darkness in humans Grillon, C.
 1996
 39 7 p. 555-
1 p.
 artikel
526 The use of light therapy in psychiatry Rosenthal, N.E.
 1996
 39 7 p. 512-
1 p.
 artikel
527 The use of RNA fingerprinting technique in the neuropsychiatry research Yamada, M.
 1996
 39 7 p. 658-
1 p.
 artikel
528 Thought disorder index (TDI) in schizotypal personality disorder Voglmaier, M.M.
 1996
 39 7 p. 549-
1 p.
 artikel
529 Three-dimensional visualization of the fronto-striato-thalamic circuitry in schizophrenia Buchsbaum, M.S.
 1996
 39 7 p. 601-
1 p.
 artikel
530 Thyroid hormone action in the brain: Hormonal crosstalk & other mechanisms in behavior Chin, W.W.
 1996
 39 7 p. 502-
1 p.
 artikel
531 Time estimation in schizophrenia Tracy, J.I.
 1996
 39 7 p. 575-
1 p.
 artikel
532 Tobacco and marijuana use increases in junior and senior high school students Gold, M.S.
 1996
 39 7 p. 629-
1 p.
 artikel
533 Topographic analyses of brain potentials in depressed patients Bruder, G.
 1996
 39 7 p. 566-
1 p.
 artikel
534 Transient versus sustained visual channels in the VBM deficits of schizophrenia Cadenhead, K.S.
 1996
 39 7 p. 577-
1 p.
 artikel
535 Treatment of binge eating disorder Agras, S.
 1996
 39 7 p. 666-
1 p.
 artikel
536 Treatment of schizophrenia: New antidopaminergic strategies Lahti, A.C.
 1996
 39 7 p. 597-
1 p.
 artikel
537 Tryptophan depletion and behavioral disinhibition in male adolescents with aggressive, disruptive behavior LeMarquand, D.G.
 1996
 39 7 p. 534-
1 p.
 artikel
538 Two homologous genes associated with early onset familial Alzheimer's disease George-Hyslop, P.St.
 1996
 39 7 p. 562-
1 p.
 artikel
539 Uncoupling of CNS serotonin and norepinephrine systems in depression Geracioti, T.D.
 1996
 39 7 p. 584-585
2 p.
 artikel
540 Understanding delusions in schizophrenia using visual scan paths Phillips, M.L.
 1996
 39 7 p. 549-550
2 p.
 artikel
541 Using MRI and MRS to investigate gray matter deficits in schizophrenia Lim, K.O.
 1996
 39 7 p. 559-
1 p.
 artikel
542 Validation of the DSM IV construct of minor depression in patients with stroke Paradiso, S.
 1996
 39 7 p. 664-
1 p.
 artikel
543 Validity of the CGI as a severity measure in schizophrenia Goldman, M.
 1996
 39 7 p. 546-547
2 p.
 artikel
544 VBR in depression: Does it predict symptom severity and response to ECT? Tornori, O.
 1996
 39 7 p. 650-
1 p.
 artikel
545 Verbal learning and memory in schizotypal personality disorder Bergman, A.
 1996
 39 7 p. 570-
1 p.
 artikel
546 Verbal learning and organization in schizotypal personality disorder Voglmaier, M.M.
 1996
 39 7 p. 576-577
2 p.
 artikel
547 Visual memory deficits in schizophrenia: Medication and ERP correlates Rabinowicz, E.F.
 1996
 39 7 p. 655-656
2 p.
 artikel
548 Visual processing is abnormal in striate and association areas in Alzheimer's disease Mentis, M.J.
 1996
 39 7 p. 662-
1 p.
 artikel
549 Visuospatial working memory in schizotypal personality disorder Lees Roitman, S.E.
 1996
 39 7 p. 577-
1 p.
 artikel
550 What is the lowest effective dose of haloperidol? Evidence from pet studies Kapur, S.
 1996
 39 7 p. 513-
1 p.
 artikel
551 Withdrawal from chronic cocaine in rats: A model of depression Baumann, M.H.
 1996
 39 7 p. 616-
1 p.
 artikel
552 Working and strategic memory changes in schizophrenia Singh, J.
 1996
 39 7 p. 569-570
2 p.
 artikel
553 Working memory and olfactory identification in schizotypal personality Park, S.
 1996
 39 7 p. 572-
1 p.
 artikel
554 Working memory as a factor in language dysfunction in schizophrenia Niznikiewicz, M.A.
 1996
 39 7 p. 569-
1 p.
 artikel
                             554 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland